By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein biomarker firm Astute Medical today announced the completion of a $13 million financing.

The financing is an extension of a Series B round completed in May that had raised $26.5 million. The San Diego firm also raised $6.2 million in a Series A round in 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.